Clostridioides difficile infection (CDI), which is caused by excessive proliferation of C. difficile, is one of the antibacterial drug-related diarrhea and enteritis. Therefore, it is important to develop a new and specific treatment method for C. difficile disinfection. The current study was focused on bacteriophage (phage) as a potential treatment. Phage binds specifically to the host bacterium and generates a bactericidal activity. In this study, the recombinant phage proteins were expressed and purified and the bindings between these proteins and C. difficile were examined using enzyme-linked immunosorbent assay (ELISA) and western blot analysis. The results of the study showed a dose- and a time-dependent binding.